140 related articles for article (PubMed ID: 18053647)
1. Neuropeptide co-release with GABA may explain functional non-monotonic uncertainty responses in dopamine neurons.
Tan CO; Bullock D
Neurosci Lett; 2008 Jan; 430(3):218-23. PubMed ID: 18053647
[TBL] [Abstract][Full Text] [Related]
2. Alterations in nigral NMDA and GABAA receptor control of the striatal dopamine level after repetitive exposures to nitrogen narcosis.
Lavoute C; Weiss M; Rostain JC
Exp Neurol; 2008 Jul; 212(1):63-70. PubMed ID: 18452916
[TBL] [Abstract][Full Text] [Related]
3. Neurokinin-1 and neurokinin-3 receptors in primate substantia nigra.
Lévesque M; Wallman MJ; Parent R; Sík A; Parent A
Neurosci Res; 2007 Mar; 57(3):362-71. PubMed ID: 17134780
[TBL] [Abstract][Full Text] [Related]
4. Metabolic changes detected by proton magnetic resonance spectroscopy in vivo and in vitro in a murin model of Parkinson's disease, the MPTP-intoxicated mouse.
Chassain C; Bielicki G; Durand E; Lolignier S; Essafi F; Traoré A; Durif F
J Neurochem; 2008 May; 105(3):874-82. PubMed ID: 18088356
[TBL] [Abstract][Full Text] [Related]
5. Striatal dysfunction increases basal ganglia output during motor cortex activation in parkinsonian rats.
Belluscio MA; Riquelme LA; Murer MG
Eur J Neurosci; 2007 May; 25(9):2791-804. PubMed ID: 17561844
[TBL] [Abstract][Full Text] [Related]
6. Explant cultures of dog substantia nigra and striatum: a model for the study of nigro-striatal dopamine neurons.
Mytilineou C; Cohen G; Dembiec-Cohen D; Van Woert M; Hwang E
J Neural Transm Suppl; 1983; 19():37-51. PubMed ID: 6321649
[TBL] [Abstract][Full Text] [Related]
7. CGP 56999A, a GABA(B) receptor antagonist, enhances expression of brain-derived neurotrophic factor and attenuates dopamine depletion in the rat corpus striatum following a 6-hydroxydopamine lesion of the nigrostriatal pathway.
Enna SJ; Reisman SA; Stanford JA
Neurosci Lett; 2006 Oct; 406(1-2):102-6. PubMed ID: 16890350
[TBL] [Abstract][Full Text] [Related]
8. Distribution of GABAergic neurons in the striatum of amygdala-kindled rats: an immunohistochemical and in situ hybridization study.
Löscher W; Schirmer M; Freichel C; Gernert M
Brain Res; 2006 Apr; 1083(1):50-60. PubMed ID: 16545783
[TBL] [Abstract][Full Text] [Related]
9. Co-localization of GABA with other neuroactive substances in the basal ganglia.
McGinty JF
Prog Brain Res; 2007; 160():273-84. PubMed ID: 17499120
[TBL] [Abstract][Full Text] [Related]
10. In vivo release of transmitters in the cat basal ganglia.
Glowinski J
Fed Proc; 1981 Feb; 40(2):135-41. PubMed ID: 6161843
[TBL] [Abstract][Full Text] [Related]
11. Partial depletion of dopamine in substantia nigra impairs motor performance without altering striatal dopamine neurotransmission.
Andersson DR; Nissbrandt H; Bergquist F
Eur J Neurosci; 2006 Jul; 24(2):617-24. PubMed ID: 16903863
[TBL] [Abstract][Full Text] [Related]
12. Neuropeptides in the basal ganglia.
Graybiel AM
Res Publ Assoc Res Nerv Ment Dis; 1986; 64():135-61. PubMed ID: 2425403
[No Abstract] [Full Text] [Related]
13. Pathophysiology of L-dopa-induced dyskinesias.
Bédard PJ; Blanchet PJ; Lévesque D; Soghomonian JJ; Grondin R; Morissette M; Goulet M; Calon F; Falardeau P; Gomez-Mancilla B; Doucet JP; Robertson GS; DiPaolo T
Mov Disord; 1999; 14 Suppl 1():4-8. PubMed ID: 10493397
[No Abstract] [Full Text] [Related]
14. An immunohistochemical study on a unique colocalization relationship between substance P and GABA in the central nucleus of amygdala.
Shigematsu N; Yamamoto K; Higuchi S; Fukuda T
Brain Res; 2008 Mar; 1198():55-67. PubMed ID: 18243164
[TBL] [Abstract][Full Text] [Related]
15. Basic research on dopamine in Parkinson's disease and the discovery of the nigrostriatal dopamine pathway: the view of an eyewitness.
Hornykiewicz O
Neurodegener Dis; 2008; 5(3-4):114-7. PubMed ID: 18322366
[TBL] [Abstract][Full Text] [Related]
16. Tyrosine hydroxylase cells appearing in the mouse striatum after dopamine denervation are likely to be projection neurones regulated by L-DOPA.
Darmopil S; Muñetón-Gómez VC; de Ceballos ML; Bernson M; Moratalla R
Eur J Neurosci; 2008 Feb; 27(3):580-92. PubMed ID: 18279311
[TBL] [Abstract][Full Text] [Related]
17. Pure autonomic failure with altered dopamine transporter imaging.
Compta Y; Martí MJ; Paredes P; Tolosa E
Arch Neurol; 2006 Apr; 63(4):604-5. PubMed ID: 16606777
[No Abstract] [Full Text] [Related]
18. Sprouting of dopamine terminals and altered dopamine release and uptake in Parkinsonian dyskinaesia.
Lee J; Zhu WM; Stanic D; Finkelstein DI; Horne MH; Henderson J; Lawrence AJ; O'Connor L; Tomas D; Drago J; Horne MK
Brain; 2008 Jun; 131(Pt 6):1574-87. PubMed ID: 18487277
[TBL] [Abstract][Full Text] [Related]
19. Zonisamide enhances delta receptor-associated neurotransmitter release in striato-pallidal pathway.
Yamamura S; Ohoyama K; Nagase H; Okada M
Neuropharmacology; 2009 Sep; 57(3):322-31. PubMed ID: 19482038
[TBL] [Abstract][Full Text] [Related]
20. Cellular principles underlying normal and pathological activity in the subthalamic nucleus.
Bevan MD; Atherton JF; Baufreton J
Curr Opin Neurobiol; 2006 Dec; 16(6):621-8. PubMed ID: 17084618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
